Assessing the effect of Mediscare on the 2012 election cycle.
One of the more… interesting… beliefs that seems to have spread along the Online Left lately is that their forthcoming campaigning against Paul Ryan’s budget reforms (henceforth to be sneeringly dismissed as ‘Mediscare’) is a clear winner for them. And if you ask them why, the members of the Online Left who are smart enough to avoid saying “Because we think that the population of | Read More »
Is Sir Donald out as Medicare czar?
Not exactly: the Politico reports that, in wake of forty-two Senators sending a letter indicating that Sir Donald Berwick is simply unacceptable for the job of Centers for Medicare and Medicaid Services (CMS) head*, Senate Democrats have made an answer to that by… giving up trying to get Berwick nominated. There’ll be no fight, no confirmation hearing, no standing on what the Democrats consider ‘principle.’ | Read More »
Proposed Medicare Czar likes pretty, pretty pictures.
Witness this map. It’s called the Dartmouth map, and as the New York Times and Hot Air notes, it was used by the Obama administration to argue that there were existing inefficiencies in the Medicare system that could be trimmed away, thus permitting a scenario where Medicare funding could be cut significantly while not sacrificing care (indeed, the map’s creators argue that it demonstrates that | Read More »
CMS: Democratic bill would *raise* health care costs.
By almost 300 billion. CMS: House health bill will hike costs $289B The House-approved healthcare overhaul would raise the costs of healthcare by $289 billion over the next 10 years, according to an analysis by the chief actuary at the Centers for Medicare and Medicaid Services (CMS). This would be infuriating, if I had taken seriously in the first place the notion that an interventionist, | Read More »
Henry Waxman doesn’t *care* what President Obama said.
And he wants to make sure that the pharmaceutical companies understand that, too. The House Energy Chair intends to retroactively remove what Waxman calls a ‘windfall’ involving Medicare D drug charges, and never mind what either the President or PhRMA thinks: Drug makers contend they have already worked out a 10-year, $80 billion cost-savings deal with the White House and crucial Senate gatekeepers on the | Read More »